91 related articles for article (PubMed ID: 11237788)
1. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.
Koksch M; Zeiger F; Wittig K; Siegemund A; Reininger CB; Pfeiffer D; Ruehlmann C
Eur J Vasc Endovasc Surg; 2001 Feb; 21(2):147-54. PubMed ID: 11237788
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic derangement in advanced peripheral occlusive arterial disease.
Koksch M; Zeiger F; Wittig K; Pfeiffer D; Ruehlmann C
Int Angiol; 1999 Dec; 18(4):256-62. PubMed ID: 10811512
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
8. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
9. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
[TBL] [Abstract][Full Text] [Related]
10. Association between platelet activation and fibrinolysis in acute stroke patients.
Wang J; Li J; Liu Q
Neurosci Lett; 2005 Aug; 384(3):305-9. PubMed ID: 15916851
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
[TBL] [Abstract][Full Text] [Related]
12. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
14. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
Liu BY; Jian YL; Zhong M; Yu YH; Wang Q; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):35-7. PubMed ID: 17259140
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients.
Beppu S; Nakajima Y; Shibasaki M; Kageyama K; Mizobe T; Shime N; Matsuda N
Anesthesiology; 2009 Dec; 111(6):1227-37. PubMed ID: 19934866
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
Cerinic MM; Valentini G; Sorano GG; D'Angelo S; Cuomo G; Fenu L; Generini S; Cinotti S; Morfini M; Pignone A; Guiducci S; Del Rosso A; Kalfin R; Das D; Marongiu F
Semin Arthritis Rheum; 2003 Apr; 32(5):285-95. PubMed ID: 12701039
[TBL] [Abstract][Full Text] [Related]
17. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
18. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
20. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
